🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thanks for having me! Enjoyed discussing the importance of peer mentoring (shoutout to #PCF_ONE program with Sarah R. Amend, Ph.D.) and highlighting the benefits of a supportive tribe (Raehannah Jamshidi, MD PhD)! #WomenInSTEM #NextGen #TeamScience

How chemotherapy drives metastasis by causing tumor cells to become significantly more mobile. Sarah R. Amend, Ph.D. Johns Hopkins Medicine joins Andrea Miyahira Prostate Cancer Foundation to discuss her work on polyaneuploid cancer cells and their increased metastatic potential > bit.ly/48IGpv7

Paper Drop from the #ShafiLab ⬇️ Center for Prostate Disease Research⁩ ⁦⁦@AmerCancerCEO⁩ ⁦NCI CCR GU Malignancies⁩ ⁦PCF Science⁩ ⁩ ⁦Gregory Chesnut⁩ ⁦Adam Sharp⁩ ⁦EllisLab_⁩ ⁦Allen Su⁩ ⁦Uniformed Services University⁩ biorxiv.org/content/10.110…

Great work from Ayesha Shafi, PhD Center for Prostate Disease Research hitting AR coactivators to initiate DNA damage and overall superior tumor response 👊🏼

This thought-provoking set of rules for science by a Nobel Prize winner would be fascinating to discuss on the Night Science Podcast! The Night Science Podcast

#PaperDrop from the #ShafiLab AR coactivators, CBP/p300, are key players in #DNArepair in #prostatecancer. Targeting them could be a new strategy for treating CRPC. Center for Prostate Disease Research @AmerCancerCEO Chris McNair Adam Sharp Lisa Butler Allen Su PCF Science nature.com/articles/s4138…

Starting off #PCFRetreat24 with the #GENI Gender Equity Networking Initiative and the keynote speaker @PamSharmaMDPhD discussing her scientific journey with challenges faced and lessons learned. PCF Science Prostate Cancer Foundation Center for Prostate Disease Research Uniformed Services University NCI CCR GU Malignancies

A man who deserved the two standing ovations regardless of his own cancer journey. Felix Feng: “I just want to thank my friends” and “Behind every clinical trial is a patient like me. Thank you.” #PCFRetreat24

Claire E Fletcher representing the PCF #GENI - Gender Equity Networking Initiative - at the #PCFRetreat24. Please fill out the survey linked to the QR code ⬇️

Best of 2024: The 9th Annual PCF Science Gender Equity Networking Initiative (GENI) Forum🥰

Polyaneuploid cancer cells drive metastasis and resist treatments in #ProstateCancer. Sarah R. Amend, Ph.D. Johns Hopkins Medicine joins Andrea Miyahira Prostate Cancer Foundation to discuss her research on polyaneuploid cancer cells (PACCs) and their role in metastasis, published in Molecular Cancer Research. #WatchNow on

Polyaneuploid cancer cells drive metastasis and resist treatments in #ProstateCancer. Sarah R. Amend, Ph.D. Johns Hopkins Medicine joins Andrea Miyahira Prostate Cancer Foundation to discuss her research on polyaneuploid cancer cells (PACCs) and their role in metastasis, published in Molecular Cancer Research. #WatchNow on

Study in PNASNews (bit.ly/4h3SpLy) by Johns Hopkins Medicine The Johns Hopkins Brady Urological Institute & Uni of Reading UoR BioSci dispels 45-yr-old #PetosParadox claiming no link btwn animal size & #cancer rates. Data say larger species have more tumors. PCF funded. More at bit.ly/43afEQI

Hopkins Med News PNASNews Johns Hopkins Medicine The Johns Hopkins Brady Urological Institute Uni of Reading UoR BioSci PCF Congrats to PCF YI George Butler! Prostate Cancer Foundation

A new study challenges Peto’s Paradox, which says larger animals are no more likely to get cancer than smaller ones. Dr. Sarah Amend from Johns Hopkins Medicine joins us to discuss the findings and what studying animal cancer rates could teach scientists. buff.ly/41jn9SO

The dual capacity for cancers to metastasize and resist systemic treatment is the tipping point for driving lethal cancer. Drs. Pienta, Goodin & Amend explore how eco-evolutionary principles can guide new interventions: acsjournals.onlinelibrary.wiley.com/doi/full/10.33… Kenneth Pienta Sarah R. Amend, Ph.D. OncoAlert

“Studying, understanding, and treating cancer using evolutionary ecology principles provides an opportunity to improve the lives of patients with cancer.” Read a new #OpenAccess article from Drs. Pienta, Goodin & Amend: acsjournals.onlinelibrary.wiley.com/doi/full/10.33… Kenneth Pienta Sarah R. Amend, Ph.D. OncoAlert

Can we disrupt cancer’s evolutionary trajectory? Drs. Pienta, Goodin & Amend examine metastasis as an ecologic invasion—and how clinicians can intervene—in their latest #OpenAccess article in CA: acsjournals.onlinelibrary.wiley.com/doi/full/10.33… Kenneth Pienta Sarah R. Amend, Ph.D. OncoAlert